US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 3.370
  • -0.630-15.75%
Close Oct 31 16:00 ET
  • 3.550
  • +0.180+5.34%
Post 19:57 ET
896.74MMarket Cap-2956P/E (TTM)

Autolus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Autolus Therapeutics Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
129.17K
-68.18%
EPS
-0.22
+16.66%
Analyst Rating
Strong Buy

Oct 31, 2024

Autolus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 12, 20242024/Q3-- / 129.170K--
Aug 8, 20192019/Q2-- / 500.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--
Mar 14, 20242023/Q40.000 / 256.000K--
DatePeriodRevenue/EstimateEarnings Call
Nov 12, 20242024/Q3-- / 129.170K--
Aug 8, 20192019/Q2-- / 500.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--
Mar 14, 20242023/Q40.000 / 256.000K--

Unlock Free Earnings Estimates

Autolus Therapeutics Earnings Reports

  • Autolus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:26 ET

  • Autolus Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 17 16:44 ET

  • Autolus Therapeutics | 10-K: FY2023 Annual Report

    Mar 21 22:17 ET

  • Autolus Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 16:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data